InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Landau Jeffrey B. Director active across 1 company, notably CytomX Therapeutics, Inc.. Cumulatively, 9 reports have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €20k. Activity tracked since 19 July 2022. The latest transaction was filed on 20 August 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
9 of 9 declarations